Abstract:Malaria is one of the major infectious diseases in the world.Approximately 300 -500 million people are infected and 1 -3 million deaths occur annually 1 .The multidrug resistance of the parasite and limitations with existing drugs (e.g., toxicity, side effects, high cost) 2 emphasize the urgent need for new drugs, ideally directed against potential new targets such as plasmodial proteases.These proteases are multifunctional: During the merozoite stage of the parasite they facilitate erythrocyte escape and subsequent reinvasion.In the trophozoite stage these enzymes are critical for the degradation of hemoglobin 3 .The falcipains are cysteine proteases belonging to the papain family (C1A).The best-studied members of this group are falcipains-1, -2 and -3.Falcipain-2 and -3 degrade hemoglobin at acidic pH.In addition, falcipain-2 degrades cytoskeletal proteins at neutral pH and thus facilitates the release of the mature merozoites.There is experimental evidence that cysteine protease inhibitors such as E-64, fluoromethyl ketones or aziridine derivatives inhibit falcipain-2 at low micromolar concentrations, and thereby block the development of the parasite 4,5 .However, a falcipain-specific inhibitor with in-vivo activity remains to be developed.It is expected that the elucidation of the structure of falcipain-2 will open new avenues for the development of antimalarial drugs with lowered toxicity and drug resistance.Towards this goal, we have crystallized recombinant falcipain-2 and determined its structure to ∼ 3.1 Å resolution.There are two major structural differences between papain and falcipain-2.First, the presence of a ∼ 20-residue N-terminal extension which is necessary for the proper folding of the mature protein 6 .Interestingly, this sequence element is functionally conserved within the plasmodial cysteine proteases 6 .Second, falcipain-2 contains a rather unique structural motif responsible for the binding of its natural substrate, hemoglobin 7 : a beta-hairpin located between the active-site residues His174 and Asn204 where it protrudes out of the core of the enzyme.On the basis of our results, we will discuss the interaction between falcipain and its substrate, hemoglobin.Additional experimental data on substrate binding and specificity will be presented.

Towards A Functional Mapping of the Blm Helicase

Structure-Function of Falcipains: Malarial Cysteine Proteases

The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site

Plasmodium falciparum cysteine protease Falcipain 3: A potential enzyme for proteolytic processing of histone acetyltransferase PfGCN5

In Silico Study Reveals How E64 Approaches, Binds to, and Inhibits Falcipain-2 of Plasmodium falciparum that Causes Malaria in Humans

Cloning and characterization of Plasmodium falciparum cysteine protease, falcipain-2B.

Structural Features Of Falcipain-3 Inhibitors: An In Silico Study

Understanding the complex formation of falstatin; an endogenous macromolecular inhibitor of falcipains

Inhibition of falcilysin from Plasmodium falciparum by interference with its closed-to-open dynamic transition

Deciphering structure, function and mechanism of Plasmodium IspD homologs from their evolutionary imprints

Biochemical Characterization of the Apicoplast-Targeted AAA+ ATPase ClpB from Plasmodium Falciparum

2-Amido-3-(1h-indol-3-yl)-n-substitued-propanamides As a New Class of Falcipain-2 Inhibitors. 1. Design, Synthesis, Biological Evaluation and Binding Model Studies

BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.

Structural Exploration of the PfBLM Helicase-ATP Binding Domain and Its Implications in the Quest for Antimalarial Therapies

Hemoglobin metabolism in the malaria parasite Plasmodium falciparum.

Disruption of Plasmodium Falciparum Histidine-Rich Protein II can affect Heme Metabolism in the Blood Stage

Identification of a specific region of Plasmodium falciparum EBL-1 that binds to host receptor glycophorin B and inhibits merozoite invasion in human red blood cells.

Functionality of the V-type ATPase during asexual growth and development of Plasmodium falciparum

Structural characterization of the Plasmodium falciparum lactate transporter PfFNT alone and in complex with antimalarial compound MMV007839 reveals its inhibition mechanism

A dual target of Plasmepsin IX and X: Unveiling the atomistic superiority of a core chemical scaffold in malaria therapy

Structural insights into the binding mechanism of Plasmodium falciparum exported Hsp40-Hsp70 chaperone pair